Stock Scan December 2017: Teva Stick, Valeant Carrot Spur Generics Revival
Executive Summary
The end-of-year stock valuations across Big Pharma jumped nearly 3% in December led by financial reassurances at Valeant and gleeful shareholder reaction to ceremonial employee sacrifices at Teva.